Story · Medicine & Biotech
Hyderabad-based startup PopVax bets on cancer mRNA vaccines priced at Rs 2.7 crore per patient
1 outlet · first reported by ThePrint Health 2d ago
Coverage, in order
-
2d agoHyderabad-based startup PopVax bets on cancer mRNA vaccines priced at Rs 2.7 crore per patient
The announcement comes amid growing global interest in personalised cancer vaccines, with companies like Moderna and BioNTech advancing similar approaches through clinical trials, with mixed results.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.